No abstract available

Coelho T., Dispenzieri A., Grogan M., Conceicao I., Waddington-Cruz M., Kristen A.V., et al. (2023). Patients with transthyretin amyloidosis enrolled in THAOS between 2018 and 2021 continue to experience substantial diagnostic delay. AMYLOID, 30(4), 445-448 [10.1080/13506129.2023.2229484].

Patients with transthyretin amyloidosis enrolled in THAOS between 2018 and 2021 continue to experience substantial diagnostic delay

Diemberger I.;
2023

Abstract

No abstract available
2023
Coelho T., Dispenzieri A., Grogan M., Conceicao I., Waddington-Cruz M., Kristen A.V., et al. (2023). Patients with transthyretin amyloidosis enrolled in THAOS between 2018 and 2021 continue to experience substantial diagnostic delay. AMYLOID, 30(4), 445-448 [10.1080/13506129.2023.2229484].
Coelho T.; Dispenzieri A.; Grogan M.; Conceicao I.; Waddington-Cruz M.; Kristen A.V.; Wixner J.; Diemberger I.; Gonzalez-Moreno J.; Maurer M.S.; Plant...espandi
File in questo prodotto:
File Dimensione Formato  
Patients with transthyretin amyloidosis enrolled in THAOS between 2018 and 2021 continue to experience substantial diagnostic delay.pdf

accesso aperto

Tipo: Versione (PDF) editoriale / Version Of Record
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione - Non commerciale - Non opere derivate (CCBYNCND)
Dimensione 903.61 kB
Formato Adobe PDF
903.61 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/958419
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 10
social impact